Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMID 28225754)

Published in Nature on February 22, 2017

Authors

Justin Eyquem1, Jorge Mansilla-Soto1, Theodoros Giavridis1, Sjoukje J C van der Stegen1, Mohamad Hamieh1, Kristen M Cunanan2, Ashlesha Odak1, Mithat Gönen2, Michel Sadelain1

Author Affiliations

1: Center for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USA.
2: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Articles cited by this

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol (2008) 10.26

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med (2013) 7.99

A human memory T cell subset with stem cell-like properties. Nat Med (2011) 7.47

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med (2003) 6.81

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor. Nat Biotechnol (2002) 5.49

Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther (2005) 2.81

Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol (2015) 2.74

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci U S A (1995) 2.68

On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity (2000) 2.48

Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods (2011) 2.30

Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering. Cell (2016) 2.02

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med (2015) 1.87

Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. Neoplasia (1999) 1.74

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells. Cancer Cell (2015) 1.74

Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol (2013) 1.70

Targeted elimination of prostate cancer by genetically directed human T lymphocytes. Cancer Res (2005) 1.67

The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol (2005) 1.64

Chimeric antigen receptor-modified T cells derived from defined CD8(+) and CD4(+) subsets confer superior antitumor reactivity in vivo. Leukemia (2015) 1.45

Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template. Sci Transl Med (2015) 1.30

Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nat Biotechnol (2014) 1.22

CAR therapy: the CD19 paradigm. J Clin Invest (2015) 1.20

Designing chimeric antigen receptors to effectively and safely target tumors. Curr Opin Immunol (2015) 1.18

Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol Res (2015) 1.17

Hematopoietic stem cell engineering at a crossroads. Blood (2011) 1.10

Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat Rev Genet (2016) 1.03

Evaluation of the percentage of peripheral T cells with two different T cell receptor alpha-chains and of their potential role in autoimmunity. J Autoimmun (2001) 1.02

Surface T-cell antigen receptor expression and availability for long-term antigenic signaling. Immunol Rev (2003) 0.95

The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes. Gene Ther (1997) 0.94

Clinical manufacturing of CAR T cells: foundation of a promising therapy. Mol Ther Oncolytics (2016) 0.93

Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome. Blood (2016) 0.88

Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery. Nucleic Acids Res (2015) 0.85

Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. Elife (2016) 0.79

Vector integration and tumorigenesis. Hum Gene Ther (2014) 0.75